Epidermal surface receptors which link pharmacological mediators to the adenylate cyclase system
- PMID: 6291566
- DOI: 10.1111/j.1365-2133.1982.tb01042.x
Epidermal surface receptors which link pharmacological mediators to the adenylate cyclase system
Abstract
The major purpose of our studies has been to investigate various stimulators of the epidermal adenylate cyclase system. We have recognized the occurrence of four distinct adenylate cyclase systems which respond respectively to catecholamine, histamine, prostaglandin and adenosine. The exposure of floating skin slices in vitro to a stimulator causes a rapid intracellular accumulation of cyclic AMP, which is always transient. Further addition of the same stimulator will not stimulate the same receptor system against the state of 'refractoriness'. The addition of any of the other stimulators can increase the cyclic AMP level. Furthermore, the fact that each stimulator can yield an 'additive' stimulatory effects leads to the conclusion that the epidermis has four distinctly specific and independent adenylate cyclase systems. Our recent investigations have been directed to the analyses of subunits of these skin surface receptor-adenylate cyclase systems. We used two experimental systems, i.e. one being a 'leaky' cell system in which its subunits such as receptor, GTP-regulatory protein and the catalytic unit (adenylate cyclase) are still linked together, and the other being independent preparations of the receptor and catalytic units (with GTP-regulatory protein). These systems allowed us to probe the cell membrane from the inside as well as from the outside. Some of the preliminary kinetic data are herein introduced.
Similar articles
-
Human skin epidermal adenylate cyclase systems: defective beta-adrenergic responsiveness in the involved epidermis of Darier's disease.Curr Probl Dermatol. 1983;11:45-58. doi: 10.1159/000408663. Curr Probl Dermatol. 1983. PMID: 6317292
-
"Leaky" epidermal cells contain a complete receptor-mediated adenylate cyclase system with an accessible GTP regulatory protein.J Invest Dermatol. 1983 Sep;81(3):241-5. doi: 10.1111/1523-1747.ep12518232. J Invest Dermatol. 1983. PMID: 6309986
-
Regulation of beta-adrenergic adenylate cyclase responsiveness of pig skin epidermis by suboptimal concentrations of epinephrine.J Invest Dermatol. 1983 Dec;81(6):549-52. doi: 10.1111/1523-1747.ep12523195. J Invest Dermatol. 1983. PMID: 6315830
-
Message transmission: receptor controlled adenylate cyclase system.Science. 1984 Sep 21;225(4668):1350-6. doi: 10.1126/science.6147897. Science. 1984. PMID: 6147897 Review.
-
Histamine receptors and cyclic AMP.Can J Physiol Pharmacol. 1980 Sep;58(9):1023-30. doi: 10.1139/y80-155. Can J Physiol Pharmacol. 1980. PMID: 6257356 Review.
Cited by
-
Immunohistochemical study of beta-adrenergic receptors in the psoriatic epidermis using an anti-alprenolol anti-idiotypic antibody.Arch Dermatol Res. 1987;279(7):439-43. doi: 10.1007/BF00412588. Arch Dermatol Res. 1987. PMID: 2829752
-
Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema.J Clin Invest. 1990 Aug;86(2):566-74. doi: 10.1172/JCI114746. J Clin Invest. 1990. PMID: 1696589 Free PMC article.
-
Inhibitory guanine nucleotide binding protein in pig epidermis: regulation of epidermal adenylate cyclase.Arch Dermatol Res. 1990;282(7):469-74. doi: 10.1007/BF00402625. Arch Dermatol Res. 1990. PMID: 1964035
-
Monoclonal antibodies to the beta-adrenergic receptor: modulation of catecholamine-sensitive adenylate cyclase by the antibody.Arch Dermatol Res. 1986;278(5):377-81. doi: 10.1007/BF00418166. Arch Dermatol Res. 1986. PMID: 3019255
-
Beta-adrenergic receptors in psoriasis: evidence for down-regulation in lesional skin.Arch Dermatol Res. 1993;285(5):300-4. doi: 10.1007/BF00371601. Arch Dermatol Res. 1993. PMID: 8397494
MeSH terms
Substances
LinkOut - more resources
Full Text Sources